Detalhe da pesquisa
1.
Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer.
Breast Cancer Res Treat
; 192(1): 153-161, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35112166
2.
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Breast Cancer Res Treat
; 193(3): 555-564, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35230585
3.
N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer.
Breast Cancer Res Treat
; 182(3): 613-622, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32504284
4.
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Breast Cancer Res Treat
; 193(3): 565, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507135
5.
A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a gynecologic oncology group study.
Gynecol Oncol
; 124(3): 569-74, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22037316
6.
Letters--in response.
Ann Intern Med
; 163(10): 806, 2015 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26571248
7.
On being a doctor. Letters.
Ann Intern Med
; 163(1): 66, 2015 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26148283
8.
Front-line Treatment with Gemcitabine, Paclitaxel, and Doxorubicin for Patients With Unresectable or Metastatic Urothelial Cancer and Poor Renal Function: Final Results from a Phase II Study.
Urology
; 89: 83-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26723185
9.
A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7.
Menopause
; 19(1): 48-53, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21900849